Toggle Nav
Close
  • Menu
  • Setting

Anti-B7-H1/PD-L1/CD274 Antibody (Adebrelimab)

Catalog No.
F1314
Anti-B7-H1/PD-L1/CD274 Antibody (Adebrelimab)
Grouped product items
SizePriceStock Qty
100ug
$90.00
Ship with 3-5 days
1mg
$270.00
Ship with 3-5 days
5mg
$702.00
Ship with 3-5 days
50mg
$2,359.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has good anti-tumor activity in solid tumors including extensive-stage small cell lung cancer (SCLC).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.56 kDa

Shipping

Dry ice

Cas No.

2247114-85-6

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

HTI-1316, SHR-1316, HTI-1088

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q9NZQ7

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG4SP

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

B7-H1 / PD-L1 / CD274

Note

Please avoid freeze-thaw cycles.